TrialDiabetologia2026
Dapagliflozin does not impair LDL catabolism and induces a shift towards a closer to normal VLDL
Bruno Vergès et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
TrialDiabetologia2026
Bruno Vergès et al.PubMed ↗Publisher ↗
No numbers read from the abstract.